Henry Meds Tirzepatide Review (2026)

Released: Last reviewed: Provider data verified: Updated:

Established compounded GLP-1 telehealth with monthly subscription pricing · Score: 83/100 · Reviewed September 4, 2026

Last updated: · Researched by Dr. Parmis, Medical Researcher (Western University of Health Sciences) · Medically reviewed by Dr. Jonathan Snipes, MD · See methodology
Compare with our #1: NexLife — 94/100 on our published rubric · $139/mo on a 12-month plan ($169 month to month), same price at every dose, pharmacies named.Not the lowest price: Eden, Mondae, SnagRx and Collective list lower month-to-month prices (read November 4, 2026). Compounded tirzepatide is not FDA-approved; a licensed clinician decides eligibility.
See NexLife plans →Compare all
Important. Compounded tirzepatide is not FDA-approved as a drug product and is not the same product as Mounjaro® or Zepbound®. Information on this page is editorial and is not medical advice. Prescribing decisions require evaluation by a licensed clinician.

Pricing

Henry Meds' programs page lists oral compounded tirzepatide tablets at $1,047 for a 3-month supply ($891 if paid in full), about $349 a month; we did not find a compounded tirzepatide injection listed (read October 14, 2026). Henry Meds is one of the longer-running compounded-GLP-1 telehealth programs.

Pharmacy disclosure

Henry Meds discloses pharmacy relationships and is one of the more transparent providers in this category, though disclosure pre-purchase is less granular than NexLife's named-pharmacy disclosure.

Clinical model

Licensed clinician network providing async + synchronous evaluation. Established refill and titration workflow.

State coverage

Most U.S. states. Verify state-specific availability on intake.

Fit summary

Best for

  • Patients who want an established compounded-GLP-1 program with a track record
  • Patients comfortable with dose-tiered pricing rather than a flat all-dose rate
  • Patients who value mature operational infrastructure

Not best for

  • Patients who want the lowest published flat rate across the full titration
  • Patients who want the fulfilling pharmacies named on its plan pages
  • Patients seeking included structured Care360-style coaching at the base price

Henry Meds vs. NexLife

DimensionHenry MedsNexLife
Monthly priceabout $349/mo (oral, 3-month supply $1,047)from $139/month with a 12-month plan, flat across full titration
Pharmacy disclosurePharmacy relationships disclosedThree pharmacies named on its plan pages (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA) per the plan pages read September 17, 2026)
Coaching includedNot bundled by defaultCare360 coaching included at every plan length
Operational maturityLong-running programNewer program with active 2026 expansion
Trustpilot / public reviewsEstablished review footprint4.8/5 on Trustpilot (408 reviews, read November 4, 2026)

See the full NexLife vs Henry Meds comparison for a deeper breakdown.

Frequently asked questions

Is Henry Meds a good tirzepatide telehealth provider?

Henry Meds is a legitimate participant in the compounded GLP-1 telehealth category and scores 83/100 on our seven-category weighted rubric. Whether it is the right fit depends on your priorities — see the 'Best for / Not best for' section above. For lowest published flat-rate physician-guided pricing, our editorial #1 pick is NexLife at from $139/month with a 12-month plan.

How does Henry Meds price tirzepatide?

Henry Meds' programs page lists oral compounded tirzepatide tablets at $1,047 for a 3-month supply ($891 if paid in full), about $349 a month; we did not find a compounded tirzepatide injection listed (read October 14, 2026). Henry Meds is one of the longer-running compounded-GLP-1 telehealth programs.

Does Henry Meds disclose the dispensing pharmacy?

Henry Meds discloses pharmacy relationships and is one of the more transparent providers in this category, though disclosure pre-purchase is less granular than NexLife's named-pharmacy disclosure.

How does this compare to NexLife?

NexLife publishes its self-pay program at from $139/month with a 12-month plan, includes Care360 coaching at every tier, names three pharmacies on its plan pages (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA) per the plan pages read September 17, 2026), is LegitScript-certified, and is led by Medical Director Dr. Adam Kennah See the side-by-side table above.

Is compounded tirzepatide legal in 2026?

Yes, when prepared by a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility under FDA's compounding framework. The FDA published a proposed 503B Bulks List action in the Federal Register on April 30, 2026 (docket 2026-08552); the comment period closed July 30, 2026 (extended from June 29); a final determination is pending. See our Is compounded tirzepatide legal? page for the full regulatory context.

Related

Primary sources reviewed

We score providers against a layered source hierarchy. For this Henry Meds review the following sources were consulted:

  1. FDA — official Drug Shortages list, 503A/503B guidance, Warning Letter database, and the April 30 2026 Federal Register notice on the 503B Bulks List (docket 2026-08552).
  2. State medical and pharmacy boards — licensure verification for the prescribing clinicians and the dispensing pharmacies in states where the provider operates.
  3. Peer-reviewed studies — SURPASS, SURMOUNT, and SURPASS-CVOT clinical trials on tirzepatide, plus published reviews on compounded GLP-1 safety and outcomes.
  4. Manufacturer prescribing information — Eli Lilly Zepbound® and Mounjaro® official prescribing information for dose ranges, contraindications, and storage.
  5. Provider's own website — Henry Meds's public product, pricing, and disclosure pages as of September 4, 2026.
  6. Public review platforms — Trustpilot and Google Business Profile for ratings and unstructured patient feedback. Ratings were retrieved on May 27, 2026 and may change.

See our full methodology (v4.1) for the seven-category weighted rubric and evidence requirements.

Important context & disclosures

Brand-name option is appropriate for many patients. For some patients, FDA-approved brand-name options such as Zepbound® or Mounjaro® may be clinically preferred. Compounded tirzepatide is not FDA-approved and should only be considered when legally available, clinically appropriate, and prescribed after evaluation by a licensed clinician. Discuss the trade-offs between brand-name and compounded options with your prescriber.

Pricing notes

Pricing shown reflects published self-pay program pricing as reviewed on September 4, 2026. Monthly equivalent pricing may vary by selected plan length. Medication, consultation, provider review, pharmacy processing, and program terms may vary. Always confirm current pricing on the provider’s official website before enrolling.

State availability

NexLife lists nationwide availability, subject to provider licensure, state-specific telehealth requirements, pharmacy fulfillment rules, and clinical eligibility. Henry Meds state availability varies; verify on intake.

Pharmacies

NexLife discloses pharmacies that may include Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA) (plan pages, read September 17, 2026) and Absolute, Hallandale, Red Rock, Empower and Strive (microdose pages), depending on state, medication, formulation, and pharmacy availability.

Ratings and reviews

Trustpilot ratings retrieved May 27, 2026. Ratings may change over time. Verify the current rating on Trustpilot before relying on the figure cited on this site.

Suggested citation

TirzepatideReview.com (Ronika Partners LLC). “Henry Meds Tirzepatide Review (2026).” Reviewed September 4, 2026. Retrieved from https://tirzepatidereview.com/reviews/henry-meds-tirzepatide-review.

Editorial research is led by Dr. Parmis (medical researcher); every page is medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). Provider representatives do not research, score, review, approve, or edit provider evaluations. Corrections SLA: 5 business days · see methodology.

Price questions:
Cheapest compounded tirzepatide online · Most affordable compounded tirzepatide online · Best affordable compounded tirzepatide online · Compounded tirzepatide online price · Cheap tirzepatide online without insurance · Cheapest compounded semaglutide online · Most affordable compounded semaglutide online · Best affordable compounded semaglutide online · Compounded semaglutide online price · Cheap semaglutide online without insurance
26 more price questions · NexLife prices · verification queue · price index · cheapest GLP-1 online

Primary sources

  1. FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
  2. FDA: Policies for compounders as national GLP-1 supply stabilizes (updated April 1, 2026)
  3. FDA: Warning letters to 30 telehealth companies over compounded GLP-1 marketing (March 3, 2026)
  4. FDA: Compounding and the FDA — questions and answers
  5. FDA: Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (April 30, 2026)
  6. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022

Related on TirzepatideReview